FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/090671 [Registered on: 10/07/2025] Trial Registered Prospectively
Last Modified On: 05/05/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Yoga & Naturopathy 
Study Design  Single Arm Study 
Public Title of Study   MANAGEMENT OF ANIDRA THROUGH PADABHYANGA AND SARPGANDHA CHURNA  
Scientific Title of Study   A COMPARATIVE STUDY TO EVALUATE THE EFFICACY OF PADABHYANGA AND SARPGANDHA CHURNA IN MANAGEMENT OF ANIDRA W.S.R. TO INSOMNIA 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ashadeep  
Designation  MD SCHOLAR  
Affiliation  Tantia university  
Address  PG DEPARTMENT OF SWASTHVRITTA AND YOGA, SRIGANGANAGAR COLLEGE OF AYURVEDIC SCIENCE AND HOSPITAL, TANTIA UNIVERSITY, SRI GANGANAGAR RAJASTHAN

Ganganagar
RAJASTHAN
335002
India 
Phone  9649449849  
Fax    
Email  ashumahal3491@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sudesh Kumar bhambu 
Designation  ASSOCIATE PROFESSOR DEPARTMENT OF SWASTHVRITTA AND YOGA 
Affiliation  Tantia university  
Address  DEPARTMENT OF SWASTHVRITTA AND YOGA, SRIGANGANAGAR COLLEGE OF AYURVEDIC SCIENCE AND HOSPITAL, TANTIA UNIVERSITY, SRIGANGANAGAR

Ganganagar
RAJASTHAN
335002
India 
Phone  9468709698  
Fax    
Email  drskb07@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sudesh Kumar bhambu  
Designation  ASSOCIATE PROFESSOR DEPARTMENT OF SWASTHVRITTA AND YOGA  
Affiliation  Tantia university  
Address  DEPARTMENT OF SWASTHVRITTA AND YOGA, SRIGANGANAGAR COLLEGE OF AYURVEDIC SCIENCE AND HOSPITAL, TANTIA UNIVERSITY SRIGANGANAGAR

Ganganagar
RAJASTHAN
335002
India 
Phone  9468709698  
Fax    
Email  drskb07@gmail.com  
 
Source of Monetary or Material Support  
PG DEPARTMENT OF SWASTHAVRITTA AND YOGA, SRI GANGANAGAR COLLEGE OF AYURVEDIC SCIENCE AND HOSPITAL, TANTIA UNIVERSITY, SRI GANGANAGAR 
 
Primary Sponsor  
Name  SRIGANGANAGAR COLLEGE OF AYURVEDIC SCIENCE TANTIA UNIVERSITY SRI GANGANAGAR  
Address  TANTIA UNIVERSITY, HANUMAN GARH ROAD RICCO, SRIGANGANAGAR, RAJASTHAN 335002  
Type of Sponsor  Other [Private Ayurveda college and Hospital ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ashadeep   Room no.9OPD of Department of Swasthvritta and Yoga  Ayurved Hospital Sriganganagar college of Ayurvedic science and Hospital Tantia University Sriganganagar
Ganganagar
RAJASTHAN 
9649449849

ashumahal3491@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee, Sri ganganagar college of ayurvedic science and hospital   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:F419||Anxiety disorder, unspecified. Ayurveda Condition: NIDRANASAH/ASVAPNAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Sarpgandha churna , Reference: Priya Nighantu , Route: Oral, Dosage Form: Churna/ Powder, Dose: 2(g), Frequency: hs, Bhaishajya Kal: Adhobhakta, Duration: 28 Days, anupAna/sahapAna: Yes(details: -Ushna Jala/ Milk), Additional Information: -NO
 
Inclusion Criteria  
Age From  20.00 Day(s)
Age To  60.00 Day(s)
Gender  Both 
Details  Individual between the age group of 20 to 60 years of either sex of insomnia for minimum one month duration.
Patient of insomnia with mild hypertension and anxiety disorders. 
 
ExclusionCriteria 
Details  Patients having major psychiatric illness like schizophrenia, depressive psychosis, epilepsy.
- Chronic alcoholics
- Patients having as Asthma, malignancies, liver cirrhosis, chronic liver failure
- Patients having cardiovascular accident, congestive cardiac failure, chronic obstructive
pulmonary disorders, meningitis, acute painful conditions. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Reduction in sign and symptoms   28days  
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in objective assessment criteria of Anidra  28days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "40"
Final Enrollment numbers achieved (India)="40" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   16/08/2025 
Date of Study Completion (India) 27/09/2025 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) 27/09/2025 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Completed 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
An interventional study will be done on Number of Patient 40 with administration of Sarpgandha churna along with Padabhyanga for twenty eight days. The patients
will be assessed on basis of subjective and objective criteria of Anidra before and after trial. Follow up will be taken on every 7th day. The data will be collected and analyzed statistically using appropriate test.
 
Close